Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) - More ammunition against surrogate end points

被引：14
作者：
Califf, RM
Granger, CB
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27705 USA
来源：
DIABETES CARE | 1998年 / 21卷 / 04期
关键词：
D O I：
10.2337/diacare.21.4.655
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：655 / 657
页数：3
相关论文
共 16 条
[1]   HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL [J].
ANTMAN, EM .
CIRCULATION, 1994, 90 (04) :1624-1630
[2]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[3]   MORTALITY FOLLOWING VENTRICULAR ARRHYTHMIA SUPPRESSION BY ENCAINIDE, FLECAINIDE, AND MORICIZINE AFTER MYOCARDIAL-INFARCTION - THE ORIGINAL DESIGN CONCEPT OF THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) [J].
EPSTEIN, AE ;
HALLSTROM, AP ;
ROGERS, WJ ;
LIEBSON, PR ;
SEALS, AA ;
ANDERSON, JL ;
COHEN, JD ;
CAPONE, RJ ;
WYSE, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2451-2455
[4]   Surrogate end points in clinical trials: Are we being misled? [J].
Fleming, TR ;
DeMets, DL .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613
[5]   NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J].
FURBERG, CD ;
PSATY, BM ;
MEYER, JV .
CIRCULATION, 1995, 92 (05) :1326-1331
[6]   SAFETY OBSERVATIONS FROM THE PILOT PHASE OF THE RANDOMIZED R-HIRUDIN FOR IMPROVEMENT OF THROMBOLYSIS (HIT-III) STUDY - A STUDY OF THE ARBEITSGEMEINSCHAFT-LEITENDER-KARDIOLOGISCHER-KRANKENHAUSARZTE (ALKK) [J].
NEUHAUS, KL ;
VONESSEN, R ;
TEBBE, U ;
JESSEL, A ;
HEINRICHS, H ;
MAURER, W ;
DORING, W ;
HARMJANZ, D ;
KOTTER, V ;
KALHAMMER, E ;
SIMON, H ;
HORACEK, T .
CIRCULATION, 1994, 90 (04) :1638-1642
[7]   EFFECT OF ORAL MILRINONE ON MORTALITY IN SEVERE CHRONIC HEART-FAILURE [J].
PACKER, M ;
CARVER, JR ;
RODEHEFFER, RJ ;
IVANHOE, RJ ;
DIBIANCO, R ;
ZELDIS, SM ;
HENDRIX, GH ;
BOMMER, WJ ;
ELKAYAM, U ;
KUKIN, ML ;
MALLIS, GI ;
SOLLANO, JA ;
SHANNON, J ;
TANDON, PK ;
DEMETS, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1468-1475
[8]   LARGE-SCALE RANDOMIZED EVIDENCE - LARGE, SIMPLE TRIALS AND OVERVIEWS OF TRIALS [J].
PETO, R ;
COLLINS, R ;
GRAY, R .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (01) :23-40
[9]   SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA [J].
PRENTICE, RL .
STATISTICS IN MEDICINE, 1989, 8 (04) :431-440
[10]   Conflict of interest in the debate over calcium-channel antagonists [J].
Stelfox, HT ;
Chua, G ;
O'Rourke, K ;
Detsky, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :101-106
12